相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Increasing global accessibility to high-level treatments for cervical cancers
C. Chargari et al.
GYNECOLOGIC ONCOLOGY (2022)
Oncologic results of fertility sparing surgery of cervical cancer: An updated systematic review
P. Morice et al.
GYNECOLOGIC ONCOLOGY (2022)
Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002)
Melis Gultekin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer The STARS Phase 3 Randomized Clinical Trial
He Huang et al.
JAMA ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer et al.
LANCET (2021)
Clinical Trial
Patrice Mathevet et al.
EUROPEAN JOURNAL OF CANCER (2021)
Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial
Xin Huang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis
Kimberly Levinson et al.
GYNECOLOGIC ONCOLOGY (2021)
Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).
Linda R. Mileshkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial
Supriya Chopra et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
N. Colombo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer
Jyoti Mayadev et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
Michael R. Migden et al.
LANCET ONCOLOGY (2020)
Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy
F. Mignot et al.
GYNECOLOGIC ONCOLOGY (2020)
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
Jyoti Mayadev et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients
Alexandre Escande et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer
Jessika Contreras et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer
Luis Chiva et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Evaluation of adjuvant vaginal vault brachytherapy in early stage cervical cancer patients
E. Bronsart et al.
CANCER RADIOTHERAPIE (2020)
Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]
Satoshi Takeuchi et al.
ONCOIMMUNOLOGY (2020)
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer
Danny Rischin et al.
GYNECOLOGIC ONCOLOGY (2020)
Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994.
Gemma Kenter et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?
Marie Gosset et al.
ANTICANCER RESEARCH (2019)
Brachytherapy: An overview for clinicians
Cyrus Chargari et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial
Samantha Cabral S. da Costa et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting
F. Amant et al.
ANNALS OF ONCOLOGY (2019)
Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial
Benedetta Guani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Revised FIGO staging for carcinoma of the cervix uteri
Neerja Bhatla et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2019)
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
David Cibula et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Tumor Shrinkage During Chemoradiation in Locally Advanced Cervical Cancer Patients: Prognostic Significance, and Impact for Image-Guided Adaptive Brachytherapy
Antoine Schernberg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial
Sudeep Gupta et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203
Ann H. Klopp et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
M. R. Migden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study
Dina Najjari Jamal et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Surgical treatment of intermediate risk lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature
David Cibula et al.
GYNECOLOGIC ONCOLOGY (2018)
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Pedro T. Ramirez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
Richard Potter et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2018)
Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study
A. Martinez et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update
Fabio Landoni et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners
Sylvain Reuze et al.
ONCOTARGET (2017)
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Marth et al.
ANNALS OF ONCOLOGY (2017)
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2016)
Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact
Renaud Mazeron et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Preoperative image-guided brachytherapy in early stage cervical cancers
Alexandre Escande et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer
Kari Tanderup et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
Alina Sturdza et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy
Renaud Mazeron et al.
RADIOTHERAPY AND ONCOLOGY (2015)
A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer
Lars-Christian Horn et al.
GYNECOLOGIC ONCOLOGY (2014)
Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: Results of the phase II RTCMIENDOMETRE French multicentre trial
Isabelle Barillot et al.
RADIOTHERAPY AND ONCOLOGY (2014)
MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective
Jacob Christian Lindegaard et al.
ACTA ONCOLOGICA (2013)
Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients
L. Cetina et al.
ANNALS OF ONCOLOGY (2013)
A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer
M. McCormack et al.
BRITISH JOURNAL OF CANCER (2013)
Complications of lymphadenectomy for gynecologic cancer
A. Achouri et al.
EJSO (2013)
A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study
J. Sehouli et al.
ANNALS OF ONCOLOGY (2012)
Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data
Remi A. Nout et al.
EUROPEAN JOURNAL OF CANCER (2012)
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer
D. Cibula et al.
GYNECOLOGIC ONCOLOGY (2012)
A Phase II Study of Intensity Modulated Radiation Therapy to the Pelvis for Postoperative Patients With Endometrial Carcinoma: Radiation Therapy Oncology Group Trial 0418
Anuja Jhingran et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Nodal-staging surgery for locally advanced cervical cancer in the era of PET
Sebastien Gouy et al.
LANCET ONCOLOGY (2012)
Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study
Claire Charra-Brunaud et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Outcomes after radical hysterectomy according to tumor size divided by 2-cm interval in patients with early cervical cancer
J. -Y. Park et al.
ANNALS OF ONCOLOGY (2011)
Long-Term Outcome and Quality of Life of Patients With Endometrial Carcinoma Treated With or Without Pelvic Radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) Trial
Remi A. Nout et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
Alfonso Duenas-Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: Meta-analysis
Hyuck Jae Choi et al.
CANCER SCIENCE (2010)
Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis
Elizabeth A. Kidd et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
R. A. Nout et al.
LANCET (2010)
A comparative study of laparoscopic extraperitoneal laparoscopy with the use of ultrasonically activated shears
Arash Rafii et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
PHYSICS CONTRIBUTIONS AND CLINICAL OUTCOME WITH 3D-MRI-BASED PULSED-DOSE-RATE INTRACAVITARY BRACHYTHERAPY IN CERVICAL CANCER PATIENTS
Cyrus Chargari et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial
Remi A. Nout et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy
Johannes C. A. Dimopoulos et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma
Elizabeth D. Euscher et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials
Claire Vale et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sentinel lymph node biopsy in gynaecological cancers: The importance of micrometastases in cervical cancer
Emile Darai et al.
SURGICAL ONCOLOGY-OXFORD (2008)
Early stage cervical cancer: Adjuvant treatment in negative lymph node cases
Enrico Sartori et al.
GYNECOLOGIC ONCOLOGY (2007)
The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer
P. Morice et al.
GYNECOLOGIC ONCOLOGY (2007)
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer
Richard Potter et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Indications for primary and secondary exenterations in patients with cervical cancer
Simone Marnitz et al.
GYNECOLOGIC ONCOLOGY (2006)
Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients
Denis Querleu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
A phase III randomized trial of postoperative pelvic irradiation in stage ib cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study
M Rotman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma
E Azria et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
C Haie-Meder et al.
RADIOTHERAPY AND ONCOLOGY (2005)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients
SE Lentz et al.
OBSTETRICS AND GYNECOLOGY (2004)
Depth of cervical stromal invasion as a prognostic factor after radical surgery for early stage cervical cancer
M Allam et al.
GYNECOLOGIC ONCOLOGY (2004)
Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2003)
Operable stages IB and II cervical carcinomas: A retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy
D Atlan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix
PW Grigsby et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Metastatic lymph nodes in patients with cervical cancer:: Detection with MR imaging and FDG PET
MJ Reinhardt et al.
RADIOLOGY (2001)
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
WA Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)